Oct 06, 2025
28:27
For every 27 shares held, investors received 28. The price per share adjusted from $0.00 to $0.00.
The split itself did not change the total investment value.
Memphasys Ltd (ASX:MEM) operates in the Biotechnology industry.
Memphasys Ltd company overviewMemphasys Ltd's most recent stock split was on October 6, 2025. It was a 28-for-27 forward split, so shareholders received 28 shares for every 27 they held.
Memphasys Ltd (ASX:MEM) has split its stock 9 times: a 1-for-20 reverse split on March 16, 2009, a 18-for-17 split on April 19, 2010, a 12-for-11 split on February 19, 2016, a 3-for-2 split on November 30, 2017, a 1-for-15 reverse split on August 27, 2018, a 63-for-62 split on March 6, 2019, a 370-for-353 split on August 23, 2022, a 143-for-137 split on December 7, 2023, and a 28-for-27 split on October 6, 2025.
Memphasys Ltd has split its stock 9 times. This history records 9 splits between March 16, 2009 and October 6, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Memphasys Ltd's 28-for-27 split on October 6, 2025, every 27 shares became 28 shares.
Memphasys Ltd has not announced a new split in our records. Its most recent split was on October 6, 2025, 1 year ago. Companies announce splits in advance, and any new ASX:MEM split will appear on this page.
Already premium?